Pandemic Live Attenuated Influenza Vaccine (PLAIV) candidate A/17/CA/2009/38 (H1N1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pandemic Live Attenuated Influenza Vaccine (PLAIV) candidate A/17/CA/2009/38 (H1N1), covering 2012-08-16 to 2012-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais [Phase 1, Phase 2]